BioLine RX Ltd ADR buy BiotechBee
Start price
03.09.23
/
50%
€1.97
Target price
31.07.25
€2.50
Performance (%)
18.78%
End price
06.09.23
€2.34
Summary
This prediction ended on 06.09.23 with a price of €2.34. The prediction had a final performance of 18.78%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioLine RX Ltd ADR | 7.563% | 7.563% |
iShares Core DAX® | 2.831% | 1.236% |
iShares Nasdaq 100 | 2.918% | 0.640% |
iShares Nikkei 225® | 2.007% | -2.135% |
iShares S&P 500 | 2.257% | 0.451% |
According to BiotechBee what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread BioLine RX Ltd ADR diskutieren
Buy mit Kursziel 2,5